rs548535414
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_022464.5(SIL1):c.645+2T>C variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000316 in 1,613,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_022464.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIL1 | NM_022464.5 | c.645+2T>C | splice_donor_variant, intron_variant | Intron 6 of 9 | ENST00000394817.7 | NP_071909.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251240Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135770
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461702Hom.: 0 Cov.: 32 AF XY: 0.0000344 AC XY: 25AN XY: 727150
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
Marinesco-Sjögren syndrome Pathogenic:4
This sequence change affects a donor splice site in intron 6 of the SIL1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SIL1 are known to be pathogenic (PMID: 16282977, 24176978). This variant is present in population databases (rs548535414, gnomAD 0.008%). Disruption of this splice site has been observed in individual(s) with Marinesco-Sjogren syndrome (PMID: 16282978). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 2624). Studies have shown that disruption of this splice site is associated with altered splicing resulting in multiple RNA products (PMID: 16282978). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
The SIL1 c.645+2T>C (p.?) variant is located in a splice donor site and has been observed in the compound heterozygous state in a family with Marinesco-Sjogren syndrome (PMID: 16282978). -
Variant summary: SIL1 c.645+2T>C is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5' splicing donor site. At least one publication reports experimental evidence that this variant affects mRNA splicing in patient cells, resulting in the in-frame skipping of exon 6 (example, Antonnen_2005). The variant allele was found at a frequency of 3.6e-05 in 251240 control chromosomes. c.645+2T>C has been reported in the literature in the compound heterozygous state in two individuals affected with Marinesco-Sjogren Syndrome (example, Antonnen_2005). These data indicate that the variant may be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 16282978). ClinVar contains an entry for this variant (Variation ID: 2624). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at